Amarin Corp Plc (AMRN): I have to agree with Kiwi on this. Amari...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	20
Posts	2630
Boards Moderated	0
Alias Born	01/27/2022

JRoon71

Re: Whalatane post# 424075

Thursday, 05/09/2024 8:50:23 AM

Thursday, May 09, 2024 8:50:23 AM

I have to agree with Kiwi on this. Amarin already knows about the migraine issue. They are aware of anything and everything that goes on with IPE.

But I also don't believe that Amarin has the time, resources, or interest to chase new indications that are not central to their goal. I believe Denner wants to focus on getting V rolled out in Europe, finish out the litigation efforts in the U.S. (whatever might come of that), possibly do something with the new formulations (LrEtEPA, MND-2119), and get this thing sold.

The other indications and formulations...colorectal cancer, migraines, FDC, etc. are likely something to be dangled in front of a BP as a future opportunity.

I may be wildly wrong, but there does not seem to be any effort or money being spent on R&D right now, which would be the big indicator that something was going on.